Oramed Granted Canadian Patent for GLP-1 Analog Capsule
JERUSALEM, May 9, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Canadian Intellectual Property Office has granted Oramed a patent titled, “Methods and Compositions for Oral Administration of Exenatide“. The patent covers Oramed’s invention of an oral glucagon-like […]
